Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation.

Publication

Citation
Walsh SP, Shahripour A, Tang H, Teumelsan N, Frie J, Zhu Y, Priest BT, Swensen AM, Liu J, Margulis M, Visconti R, Weinglass A, Felix JP, Brochu RM, Bailey T, Thomas-Fowlkes B, Alonso-Galicia M, Zhou X, Pai LY, Corona A, Hampton C, Hernandez M, Bentley R, Chen J, Shah K, Metzger J, Forrest M, Owens K, Tong V, Ha S, Roy S, Kaczorowski GJ, Yang L, Parmee E, Garcia ML, Sullivan K, Pasternak A.: Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation. ACS Med Chem Lett, Volume 6 (7), 2015
Authors
Alonso-Galicia M, Bailey T, Bentley R, Brochu RM, Chen J, Corona A, Felix JP, Forrest M, Frie J, Garcia ML, Ha S, Hampton C, Hernandez M, Kaczorowski GJ, Liu J, Margulis M, Metzger J, Owens K, Pai LY, Parmee E, Pasternak A., Priest BT, Roy S, Shah K, Shahripour A, Sullivan K, Swensen AM, Tang H, Teumelsan N, Thomas-Fowlkes B, Tong V, Visconti R, Walsh SP, Weinglass A, Yang L, Zhou X, Zhu Y
Journal
ACS Med Chem Lett
Year
2015
PubMed
26191360
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc